A US Multi-center, Prospective, Non-interventional, Long-term, Effectiveness and Safety Study of Patients Treated with SKYTROFA (lonapegsomatropin) (SkybriGHt)
Ages: 1 to 18 years old on treatment of SKYTROFA (Lonapegsomatropin)
- Patients are managed according to routine clinical care.
- Clinical Outcome Assessments (COAs) are collected at minimum of every 6 months, or whenever the patient visits the site as per the standard of care.
- Patients are followed for at least 5 years or whenever they stop taking SKYTROFA.
Interested? Either call Dr. Miller's Research team at 612-624-0519 or email at [email protected]
Also, the study can be found on Clinical Trials.gov at: